Literature DB >> 10681717

Analysis of T-cell clones in systemic lupus erythematosus.

M Converso1, M T Bertero, A Vallario, F Caligaris-Cappio.   

Abstract

BACKGROUND AND
OBJECTIVE: It is fairly well established that T-helper (TH)((1)) cells play a role in the pathogenesis of organ-specific autoimmune diseases, while their role and their relationship with TH((2)) cells is far from being defined in systemic lupus erythematosus (SLE). To address this issue, six female patients who fulfilled the American Rheumatism Association criteria for the diagnosis of SLE were studied. DESIGN AND METHODS: We analyzed the intracellular production of cytokines by T-cells from the peripheral blood (PB). Then, we established T-cell clones (TCC) from the peripheral blood (PB) of all cases as well as from the synovial fluid of one patient with an articular flare-up.
RESULTS: The percentages of IL-4 positive and IFN-g positive PB T-cells were not different between SLE patients and normal controls. When 93 TCC (67 CD4(+), 23 CD8(+)) from the PB of 5 different SLE patients were compared to 118 TCC (94 CD4(+), 23 CD8(+)) from 5 healthy controls no statistical difference was observed between SLE and controls in terms of TH((1)), TH((2)) or TH((0)) phenotype. However, SLE clones showed a reduced ability to secrete IL-10 (p = 0. 002). In contrast, the analysis of the 30 clones obtained from synovial fluid revealed that 11/23 CD4(+) clones were TH((1)), 12/23 were TH((0)), 2/7 CD8(+ )clones were TH((1)) and 5/7 were TH((0)). No TH((2)) clones were obtained from the synovial fluid. INTERPRETATION AND
CONCLUSIONS: The data suggest that the T-cell subsets operating in actively inflamed organs of SLE may belong to the TH((1)) and TH((0)) subsets.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681717

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.

Authors:  Ruth Fritsch-Stork; Daniela Müllegger; Karl Skriner; Beatrice Jahn-Schmid; Josef S Smolen; Günter Steiner
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

2.  Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.

Authors:  E Robak; H Niewiadomska; T Robak; J Bartkowiak; J Z Błoński; A Woźniacka; L Pomorski; A Sysa-Jedrezejowska
Journal:  Mediators Inflamm       Date:  2001-08       Impact factor: 4.711

3.  Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus.

Authors:  E Robak; P Smolewski; A Woźniacka; A Sysa-Jedrzejowska; T Robak
Journal:  Mediators Inflamm       Date:  2004-06       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.